Top 5 Stocks To Buy For 2019

tags:ABTX,NTK,EGY,CYAD,KMG,

Yesterday, small cap security stock Patriot One Technologies (OTCQB: PTOTF; TSE: PAT.V) announced that its award-winning PATSCAN CMR (Cognitive Microwave Radar) concealed weapons detection system had received Industry Canada (IC) certification for commercial use in Canada with initial deployments to be undertaken in collaboration with law enforcement and government agency personnel at several strategic locations. However and due to the operational and sensitive nature of their activities, the law enforcement organization names and installation locations are withheld under non-disclosure agreements. The planned deployment of the PATSCAN CMR by these organizations is currently for internal, non-public use, and will focus on physical installation processes, fine tuning weapons profiles and ongoing software validation studies.

Top 5 Stocks To Buy For 2019: Allegiance Bancshares, Inc.(ABTX)

Advisors' Opinion:

• [By Ethan Ryder]

  Allegiance Bancshares (NASDAQ:ABTX)’s share price hit a new 52-week high and low during mid-day trading on Friday . The company traded as low as $42.80 and last traded at $41.40, with a volume of 51295 shares. The stock had previously closed at $40.75.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Allegiance Bancshares (ABTX)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Stocks To Buy For 2019: Nortek Inc.(NTK)

Advisors' Opinion:

• [By Stephan Byrd]

  News articles about Nortek (NASDAQ:NTK) have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Nortek earned a coverage optimism score of 0.21 on Accern’s scale. Accern also gave media stories about the construction company an impact score of 47.207131440996 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

• [By Stephan Byrd]

  NetKoin (NTK) is a token. Its genesis date was January 7th, 2018. NetKoin’s total supply is 99,508,709,867 tokens. The official website for NetKoin is www.netkoin.com. NetKoin’s official Twitter account is @netkoin and its Facebook page is accessible here.

• [By Logan Wallace]

  Neurotoken (CURRENCY:NTK) traded down 8.5% against the dollar during the 1 day period ending at 22:00 PM Eastern on September 2nd. One Neurotoken token can currently be purchased for approximately $0.0421 or 0.00000579 BTC on cryptocurrency exchanges including BCEX, YoBit, Tidex and Cobinhood. In the last seven days, Neurotoken has traded 17.7% lower against the dollar. Neurotoken has a total market capitalization of $3.41 million and approximately $211,773.00 worth of Neurotoken was traded on exchanges in the last day.

Top 5 Stocks To Buy For 2019: Vaalco Energy Inc(EGY)

Advisors' Opinion:

• [By Money Morning Staff Reports]

  But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we'll show you a small-cap stock with great profit potential in its future…

  Penny Stock Current Share Price Law Month's Gain  Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85% Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40% Vivis Inc. (Nasdaq: VVUS) $0.77 150.41% Adomani Inc. (Nasdaq: ADOM) $1.49 137.68% NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88% Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06% Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12% ArQule Inc. (Nasdaq: ARQL) $4.88 90.74% LiqTech International Inc. (NYSE: LIQT) $0.66 85.60% Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

  While last month's gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

• [By Joseph Griffin]

  VAALCO Energy, Inc. (NYSE:EGY)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $2.53, but opened at $2.59. VAALCO Energy shares last traded at $2.75, with a volume of 2086739 shares trading hands.

• [By Lisa Levin] Gainers Cara Therapeutics, Inc. (NASDAQ: CARA) rose 18.2 percent to $13.71 in pre-market trading. Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma entered into ex-U.S. licensing agreement to commercialize KORSUVA™ injection in dialysis patients with pruritus. Heat Biologics, Inc. (NASDAQ: HTBX) shares rose 10.6 percent to $2.20 in pre-market trading after surging 12.43 percent on Tuesday. VAALCO Energy, Inc. (NYSE: EGY) rose 10.5 percent to $2.37 in pre-market trading after dropping 10.04 percent on Tuesday. Boxlight Corporation (NASDAQ: BOXL) rose 8.3 percent to $7.15 in pre-market trading after falling 16.03 percent on Tuesday. Tiffany & Co. (NYSE: TIF) rose 7.8 percent to $110.25 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY2018 earnings guidance. Heat Biologics, Inc. (NASDAQ: HTBX) shares rose 7.1 percent to $2.13 in pre-market trading. after climbing 12.43 percent on Tuesday. Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) rose 5.9 percent to $20.01 in pre-market trading after reporting positive Phase 2 Part B data showing treatment with palovarotene significantly reduces new bone growth in patients with FOP. Under Armour, Inc. (NYSE: UA) rose 3.5 percent to $18.44 in pre-market trading. Aegean Marine Petroleum Network Inc. (NYSE: ANW) shares rose 3.5 percent to $2.95 in pre-market trading. MetLife, Inc. (NYSE: MET) rose 3.2 percent to $50.00 in pre-market trading after reporting a $1.5 billion buyback plan. Lowe's Companies, Inc. (NYSE: LOW) rose 3.2 percent to $88.51 in pre-market trading. Lowe's reported downbeat results for its first quarter on Wednesday.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

• [By Lisa Levin] Gainers Cara Therapeutics, Inc. (NASDAQ: CARA) shares surged 42.76 percent to close at $16.56 on Wednesday in reaction to a new licensing agreement with Europe-based Vifor Pharma. As part of the agreement, the biopharmaceutical company that alleviates pain licensed worldwide rights (except U.S., Japan, and South Korea) to Vifor Pharma to commercialize its KORSUVA therapy to Vifor $70 million. Yangtze River Port and Logistics Limited (NASDAQ: YRIV) gained 31.28 percent to close at $7.05 on Wednesday. Tiffany & Co. (NYSE: TIF) climbed 23.29 percent to close at $126.05 after the company reported upbeat results for its first quarter and raised its FY2018 earnings guidance. EVO Payments, Inc. (NASDAQ: EVOP) gained 18.88 percent to close at $19.02. EVO Payments priced its IPO at $16 per share. Carver Bancorp, Inc. (NASDAQ: CARV) rose 16.1 percent to close at $6.85. USA Technologies, Inc. (NASDAQ: USAT) gained 15.68 percent to close at $13.65 after announcing pricing of public offering. eXp World Holdings, Inc. (NASDAQ: EXPI) shares jumped 15.01 percent to close at $17.70. Geron Corporation (NASDAQ: GERN) gained 14.99 percent to close at $4.68. Evolus, Inc. (NASDAQ: EOLS) rose 14.62 percent to close at $19.36. Ralph Lauren Corporation (NYSE: RL) shares rose 14.34 percent to close at $133.33 after the company reported stronger-than-expected results for its fourth quarter. Turtle Beach Corporation (NASDAQ: HEAR) jumped 13.26 percent to close at $17.34 on Wednesday. Turtle Beach S-3 showed registration for 1.857 million share common stock offering via selling holders. Communications Systems, Inc. (NASDAQ: JCS) rose 13.18 percent to close at $3.95. Communications Systems reported establishment of special committee to explore strategic alternatives. Immutep Limited (NASDAQ: IMMP) shares climbed 12.95 percent to close at $2.53. xG Technology, Inc. (NASDAQ: XGTI) rose 12.64 percent to close at $0.8561 after the company&rsq

Top 5 Stocks To Buy For 2019: Celyad SA(CYAD)

Advisors' Opinion:

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering. Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET. XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday. Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results. Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday. RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday. Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering. Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading. Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements. Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results. CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering
• [By Lisa Levin] Gainers Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8. Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica. DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance. eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results. Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results. SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results. Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results. Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36. Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday. ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial. Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70. Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday. Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
• [By Lisa Levin]

  Breaking news

  Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis, Inc. (NASDAQ: ABAX) for $83 per share in cash. Boot Barn Holdings Inc (NYSE: BOOT) reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. CELYAD SA/ADR (NASDAQ: CYAD) reported launch of 1.8 million share offering. Verastem Inc (NASDAQ: VSTM) shares dropped 12 percent in pre-market trading after announcing a $35 million common stock offering.

• [By Max Byerly]

  Shares of CELYAD SA/ADR (NASDAQ:CYAD) have been assigned a consensus recommendation of “Buy” from the six analysts that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $53.00.

Top 5 Stocks To Buy For 2019: KMG Chemicals, Inc.(KMG)

Advisors' Opinion:

• [By Shane Hupp]

  KMG Chemicals (NYSE:KMG) released its quarterly earnings data on Monday. The specialty chemicals company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $0.98 by $0.28, MarketWatch Earnings reports. The firm had revenue of $122.39 million for the quarter, compared to the consensus estimate of $121.10 million. KMG Chemicals had a net margin of 11.87% and a return on equity of 16.21%.

• [By Joseph Griffin]

  Brown Advisory Inc. increased its stake in KMG Chemicals, Inc. (NYSE:KMG) by 37.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 176,895 shares of the specialty chemicals company’s stock after acquiring an additional 48,374 shares during the period. Brown Advisory Inc.’s holdings in KMG Chemicals were worth $13,051,000 at the end of the most recent reporting period.

• [By Motley Fool Staff]

  KMG Chemicals (NYSE:KMG) Q3 2018 Earnings Conference CallJun. 11, 2018 5:00 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Joseph Griffin]

  Morgan Dempsey Capital Management LLC lowered its stake in KMG Chemicals, Inc. (NYSE:KMG) by 57.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,424 shares of the specialty chemicals company’s stock after selling 20,490 shares during the period. Morgan Dempsey Capital Management LLC owned 0.10% of KMG Chemicals worth $925,000 at the end of the most recent quarter.